An open-label, single-arm study to determine the excretion balance and metabolic disposition of [14C]GW642444 administered as a single dose of an oral solution to healthy male volunteers
Completed
- Conditions
- AsthmaCOPD10024970
- Registration Number
- NL-OMON34294
- Lead Sponsor
- GlaxoSmithKline
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 6
Inclusion Criteria
1.Healthy male aged between 30 and 55 years inclusive, at the time of signing the informed consent.
2.Body Mass Index (BMI) within the range 18.5-29.0 kg/m2.
3.Subjects who are current non-smokers, who have not used any tobacco products in the 12 month period preceding the screening visit, and have a pack history of * 5 pack years.
Exclusion Criteria
1.Suffering from: hepatitis B, cancer or HIV/AIDS. In case of participation in another drug study within 60 days before the start of this study or being a blood donor within 60 days from the start of the study. In case of donating more than 1.5 liters of blood in the 10 months prior the start of this study.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method <p>Pharmacokinetics<br /><br>Safety</p><br>
- Secondary Outcome Measures
Name Time Method <p>n.a.</p><br>